<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00592657</url>
  </required_header>
  <id_info>
    <org_study_id>JIMSONWEED</org_study_id>
    <nct_id>NCT00592657</nct_id>
  </id_info>
  <brief_title>Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions</brief_title>
  <official_title>Incidence of Rhabdomyolysis Among Pediatric and Adolescent Patients Admitted for Jimsonweed (Datura Stramonium) Ingestions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akron Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akron Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective chart review to determine the presence of rhabdomyolysis among patients
      admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk
      factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The presence of rhabdomyolysis based on serum CK concentrations in patients admitted with history of Jimsonweed ingestion.</measure>
    <time_frame>From admission until discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function, liver function, vital signs, physical exam</measure>
    <time_frame>From admission until discharge</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Rhabdomyolysis</condition>
  <condition>Myoglobinuria</condition>
  <condition>Hemoglobinuria</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients diagnosed with rhabdomyolysis and no history of jimsonweed ingestion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients diagnosed with rhabdomyolysis and history of jimsonweed ingestion</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with rhabdomyolysis/ myoglobinuria/ hemoglobinuria (in-patient,
        out-patient, ER visit) at a CHMCA facility
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted to CHMCA between 1/1/1997 to 12/31/2007 with a qualifying ICD-9 diagnosis
             code for rhabdomyolysis, myoglobinuria, and hemoglobinuria (728.88, 791.2, 791.3)or
             other ICD-9 codes identified during the study

          -  between the ages of 0-21 years at diagnosis

        Exclusion Criteria:

          -  rhabdomyolysis or serum CK concentrations not actually documented

          -  patient admitted to the burn center

          -  patient &gt; 21 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martha Blackford</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHMCA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Medical Center of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Forrester MB. Jimsonweed (Datura stramonium) exposures in Texas, 1998-2004. J Toxicol Environ Health A. 2006 Oct;69(19):1757-62.</citation>
    <PMID>16905506</PMID>
  </reference>
  <reference>
    <citation>Ertekin V, SelimoÄŸlu MA, Altinkaynak S. A combination of unusual presentations of Datura stramonium intoxication in a child: rhabdomyolysis and fulminant hepatitius. J Emerg Med. 2005 Feb;28(2):227-8.</citation>
    <PMID>15707824</PMID>
  </reference>
  <reference>
    <citation>Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007 Mar;18(2):90-100.</citation>
    <PMID>17338959</PMID>
  </reference>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2008</study_first_submitted>
  <study_first_submitted_qc>January 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2008</study_first_posted>
  <last_update_submitted>July 25, 2008</last_update_submitted>
  <last_update_submitted_qc>July 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Martha Blackford PharmD</name_title>
    <organization>CHMCA</organization>
  </responsible_party>
  <keyword>retrospective chart review</keyword>
  <keyword>Jimsonweed ingestion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemoglobinuria</mesh_term>
    <mesh_term>Rhabdomyolysis</mesh_term>
    <mesh_term>Myoglobinuria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

